Zeng Xiaofeng

He graduated from the Department of Basic Medical Sciences, Shanghai First Medical College in 1984. In 1995, he received the Ivy Wu Fellowship to study immunopathology at the University of Hong Kong. In 1998, he received a strategic partnership program from the Ministry of Health to systematically study GCP at Janssen-Ortho Inc. in Canada. He is the Chief Physician and Dr. of Rheumatology and Immunology, and a doctoral/postdoctoral supervisor. From 2002 to 2010, he served as the Deputy Director of the Department of Internal Medicine and was formerly the Director of the Department of Rheumatology and Immunology. He also served as the Director of the National Clinical Research Center for Skin and Immune Diseases. He is a member of the 13th Beijing Municipal Committee of the Chinese People's Political Consultative Conference and a recipient of the State Council Special Allowance.

He has long been dedicated to basic and clinical research on various rheumatic and immunological diseases, specializing in the diagnosis and treatment of complex and difficult-to-treat conditions, including systemic lupus erythematosus, rheumatoid arthritis, vasculitis, myositis, dermatomyositis, scleroderma, and Sjögren's syndrome. He is the chief scientist of a National Key Research and Development Program project during the 13th Five-Year Plan period, and the principal investigator of multiple National Natural Science Foundation of China projects. He has also led projects under the 11th Five-Year Plan Science and Technology Support Program and the 12th Five-Year Plan National High Technology Research and Development Program (863 Program). He was the chief scientist of a National Key Research and Development Program project during the 13th Five-Year Plan period and a member of the drafting group for the application guidelines of the 14th Five-Year Plan National Key Research and Development Program. He has published over 200 SCI articles as first author or corresponding author, with a total score exceeding 600. As the chief editor, he presided over the writing of the 3rd edition of the national-level planned textbook for postgraduate medical students in higher education institutions, "Rheumatology and Immunology", and the 2nd edition of the national-level planned textbook for standardized training of resident physicians, "Internal Medicine: Rheumatology and Immunology". He was also the deputy chief editor of the "Internal Medicine" textbook and the chief editor and translator of several monographs, including "Rheumatoid Syndromes", "Advanced Course in Rheumatology and Immunology", and "Harrison's Rheumatology".

The research project "Serological Study and Clinical Application of Early Diagnosis of Rheumatoid Arthritis" won the third prize of the Chinese Medical Science and Technology Award in 2005. The research project "Pathogenesis and Diagnostic Methodology of Systemic Lupus Erythematosus" won the second prize of the Chinese Medical Science and Technology Award, the third prize of the Beijing Science and Technology Award, and the second prize of the Ministry of Education Science and Technology Progress Award in 2009. The research project "Key Technology Research to Improve the Diagnosis and Treatment of Pulmonary Hypertension" won the first prize of the Ministry of Education Science and Technology Progress Award and the third prize of the Beijing Science and Technology Award in 2013. He was selected as one of the top 100,000 scientists globally in 2020, ranked 6th internationally (1st in mainland China) in the big data analysis of SCI papers published in rheumatology in 2020, ranked 4th in academic influence among scholars in the field of rheumatology and immunology in China, and ranked first in the number of papers published between 2012 and 2021.